BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 11564061)

  • 1. Anaplastic large cell lymphoma: pathological, molecular and clinical features.
    Falini B
    Br J Haematol; 2001 Sep; 114(4):741-60. PubMed ID: 11564061
    [No Abstract]   [Full Text] [Related]  

  • 2. NPM/ALK rearrangements in indolent cutaneous lesions.
    Hernández F; López O; Estivill C; Baiget M; Pujol RM; Bordes R; Nomdedéu JF
    Leukemia; 1999 Aug; 13(8):1291-2. PubMed ID: 10450759
    [No Abstract]   [Full Text] [Related]  

  • 3. Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.
    Morris SW; Kirstein MN; Valentine MB; Dittmer KG; Shapiro DN; Saltman DL; Look AT
    Science; 1994 Mar; 263(5151):1281-4. PubMed ID: 8122112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pathologic and clinical spectrum of anaplastic large cell lymphoma and correlation with ALK gene dysregulation.
    Kinney MC; Kadin ME
    Am J Clin Pathol; 1999 Jan; 111(1 Suppl 1):S56-67. PubMed ID: 9894470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of t(2;5)(p23;q35)-associated Ki-1 lymphoma with immunohistochemistry.
    Shiota M; Fujimoto J; Takenaga M; Satoh H; Ichinohasama R; Abe M; Nakano M; Yamamoto T; Mori S
    Blood; 1994 Dec; 84(11):3648-52. PubMed ID: 7949120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alk+ CD30+ lymphomas: a distinct molecular genetic subtype of non-Hodgkin's lymphoma.
    Morris SW; Xue L; Ma Z; Kinney MC
    Br J Haematol; 2001 May; 113(2):275-95. PubMed ID: 11380391
    [No Abstract]   [Full Text] [Related]  

  • 7. Novel ALK fusion in anaplastic large cell lymphoma involving EEF1G, a subunit of the eukaryotic elongation factor-1 complex.
    Palacios G; Shaw TI; Li Y; Singh RK; Valentine M; Sandlund JT; Lim MS; Mullighan CG; Leventaki V
    Leukemia; 2017 Mar; 31(3):743-747. PubMed ID: 27840423
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of anaplastic large cell lymphoma, ALK positive, primary presented in the skin and relapsed with systemic involvement and leukocytosis after years of follow-up period.
    Hosoi M; Ichikawa M; Imai Y; Kurokawa M
    Int J Hematol; 2010 Nov; 92(4):667-8. PubMed ID: 20976631
    [No Abstract]   [Full Text] [Related]  

  • 9. The cytoplasmic truncated receptor tyrosine kinase ALK homodimer immortalizes and cooperates with ras in cellular transformation.
    Simonitsch I; Polgar D; Hajek M; Duchek P; Skrzypek B; Fassl S; Lamprecht A; Schmidt G; Krupitza G; Cerni C
    FASEB J; 2001 Jun; 15(8):1416-8. PubMed ID: 11387242
    [No Abstract]   [Full Text] [Related]  

  • 10. Large-cell anaplastic lymphoma-specific translocation (t[2;5] [p23;q35]) in Hodgkin's disease: indication of a common pathogenesis?
    Orscheschek K; Merz H; Hell J; Binder T; Bartels H; Feller AC
    Lancet; 1995 Jan; 345(8942):87-90. PubMed ID: 7815887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleolar localization of the nucleophosmin-anaplastic lymphoma kinase is not required for malignant transformation.
    Mason DY; Pulford KA; Bischof D; Kuefer MU; Butler LH; Lamant L; Delsol G; Morris SW
    Cancer Res; 1998 Mar; 58(5):1057-62. PubMed ID: 9500471
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anaplastic large cell lymphoma].
    Suzukawa K; Kojima H; Nagasawa T
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):298-300. PubMed ID: 9851144
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffuse large cell, B-cell type lymphoma with a novel translocation (2;22)(p23;q11.2).
    Park JP; Curran MJ; Levy NB; Davis TH; Elliott JH; Mohandas TK
    Cancer Genet Cytogenet; 1997 Jul; 96(2):118-22. PubMed ID: 9216718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The t(2;5) in human lymphomas.
    Kadin ME; Morris SW
    Leuk Lymphoma; 1998 Apr; 29(3-4):249-56. PubMed ID: 9684923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [ALK+ diffuse large B-cell lymphoma].
    Parrens M
    Ann Pathol; 2012 Oct; 32(5):351-5. PubMed ID: 23141944
    [No Abstract]   [Full Text] [Related]  

  • 16. Translocations and mutations involving the nucleophosmin (NPM1) gene in lymphomas and leukemias.
    Falini B; Nicoletti I; Bolli N; Martelli MP; Liso A; Gorello P; Mandelli F; Mecucci C; Martelli MF
    Haematologica; 2007 Apr; 92(4):519-32. PubMed ID: 17488663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of NPM-ALK DNA rearrangement in CD30 positive anaplastic large cell lymphoma.
    Waggott W; Lo YM; Bastard C; Gatter KC; Leroux D; Mason DY; Boultwood J; Wainscoat JS
    Br J Haematol; 1995 Apr; 89(4):905-7. PubMed ID: 7772531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The activated anaplastic lymphoma kinase increases cellular proliferation and oncogene up-regulation in rat 1a fibroblasts.
    Wellmann A; Doseeva V; Butscher W; Raffeld M; Fukushima P; Stetler-Stevenson M; Gardner K
    FASEB J; 1997 Oct; 11(12):965-72. PubMed ID: 9337149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The (2;5)(p23;q35) translocation in cell lines derived from malignant lymphomas: absence of t(2;5) in Hodgkin-analogous cell lines.
    Dirks WG; Zaborski M; Jäger K; Challier C; Shiota M; Quentmeier H; Drexler HG
    Leukemia; 1996 Jan; 10(1):142-9. PubMed ID: 8558920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the t(2;5) (p23;q35) translocation in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease.
    Wood GS
    Leuk Lymphoma; 1998 Mar; 29(1-2):93-101. PubMed ID: 9638979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.